Short-term nonhormonal and nonsteroid treatment in West syndrome

Epilepsia

Volumn 44, Issue 8, 2003, Pages 1085-1088

  Capovilla, Giuseppe ^a   Beccaria, Francesco ^a   Montagnini, Allesandra ^a   Cusmai, Raffaella ^b   Franzoni, Emilio ^c   Moscano, Filomena ^c   Coppola, Giangennero ^d   Carotenuto, Marco ^d   Gobbi, Giuseppe ^e   Seri, Stefano ^f   Nabbout, Rima ^g   Vigevano, Federico ^d  

^a CARLO POMA HOSPITAL   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e MAGGIORE HOSPITAL   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Epilepsy; Infantile spasms; Treatment; West syndrome

Indexed keywords

HORMONE; NITRAZEPAM; STEROID; VIGABATRIN;

AGE; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HYPSARRHYTHMIA; INFANT; MALE; MULTICENTER STUDY; MUSCLE SPASM; NEWBORN HYPOXIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; WEST SYNDROME;

ANTICONVULSANTS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NITRAZEPAM; RECURRENCE; RETROSPECTIVE STUDIES; SPASMS, INFANTILE; TREATMENT OUTCOME; VIDEO RECORDING; VIGABATRIN;

EID: 0042572288     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.55402.x     Document Type: Article

References (39)

1. Riikonen R, Donner M. ACTH therapy in infantile spasms: side effects. Arch Dis Child 1980;55:664-72.
2. Ito M, Aiba H, Hashimoto K, et al. Low-dose ACTH therapy for West syndrome: initial effects and long-term outcome. Neurology 2002;58:110-4.
3. Singer WD, Rabe EF, Haller JS. The effect of ACTH therapy upon infantile spasms. J Pediatr 1980;96:485-9.
4. Riikonen R. A long-term follow-up study of 214 children with the syndrome of infantile spasms. Neuropediatrics 1982;13:14-23.
5. Snead OC, Benton JW, Hosey LC, et al. Treatment of infantile spasms with high-dose ACTH: efficacy and plasma levels of ACTH and cortisol. Neurology 1989;39:1027-31.
6. Baram TZ, Mitchell WG, Toumay A, et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996;97:375-9.
7. Chiron C, Dumas C, Jambaque I, et al. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 1997;26:389-95.
8. Vigevano F, Cilio R. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997;38:1270-4.
9. Appelton RE, Mumford JP, Peters ACB, et al. Placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 1999;40:1627-33.
10. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:180-1.
11. Lawden MC, Eke T, Degg C, et al. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 1999;67:716-22.
12. Iannetti P, Spalice A, Perla FM, et al. Visual field constriction in children with epilepsy on vigabatrin treatment. Pediatrics 2000;106:838-42.
13. Luchetti A, Amadi A, Gobbi G. Visual field defects associated with vigabatrin monotherapy in children. J Neurol Neurosurg Psychiatry 2000;69:566.
14. Comaish IF, Gorman C, Brimlow GM, et al. The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms. Doc Ophthalmol 2002;104:195-212.
15. Harding GF, Spencer EL, Wild JM, et al. Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children. Neurology 2002;58:1261-5.
16. Riikonen R. Steroids or vigabatrin in the treatment of infantile spasms? Pediatr Neurol 2000;23:403-8.
17. Ito M, Takao T, Okuno T, et al. Sequential CT studies of 24 children with infantile spasms on ACTH therapy. Dev Med Child Neurol 1983;25:475-80.
18. Maeda H, Furune S, Nomura K, et al. Decrease of N-acetylaspartate after ACTH therapy in patients with infantile spasms. Neuropediatrics 1997;28:262-7.
19. Ito M, Seki T, Takuma Y. Current therapy for West syndrome in Japan. J Child Neurol 2000;15:424-8.
20. Shields WD. West's syndrome. J Child Neurol 2002;17:S76-9.
21. Mikati MA, Lepejian GA, Holmes GL. Medical treatment of patients with infantile spasms. Clin Neuropharmacol 2002:25:61-70.
22. Rintahaka PJ, Nakagawa JA, Shewmon DA, et al. Incidence of death in patients with intractable epilepsy during nitrazepam treatment. Epilepsia 1999;40:492-6.
23. Bryant AE, Dreifuss FE. Valproic acid hepatic fatalities, III: U.S. experience since 1986. Neurology 1996;47:465-9.
24. Nabbout R, Melki I, Gerbaka B, et al. Infantile spasms in Down syndrome: good response to a short course of vigabatrin. Epilepsia 2001;42:1580-3.
25. Sirven JI, Sperling M, Wingerchuk DM. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev 2001;3:CD001902.
26. Bednarek N, Motte J, Soufflet C, et al. Evidence of late onset epileptic spasms. Epilepsia 1998;39:32-9.
27. Dulac O. What is West syndrome? Brain Dev 2001;23:447-52.
28. Tassinari CA, Bureau M, Dravet C, et al. Epilepsy with continuous spikes and waves during slow sleep, otherwise described as ESES (epilepsy with electrical status epilepticus during slow sleep). In: Roger J, Bureau M, Dravet C et al., eds. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. London: John Libbey Eurotext Ltd., 1992:245-56.
29. Veggiotti P, Beccaria F, Guerrini R, et al. Continuous spike-and-wave activity during slow-wave sleep: syndrome or EEG pattern? Epilepsia 1999;40:1593-601.
30. Dulac O. Epileptic encephalopathy. Epilepsia 2001;42(S3):23-6.
31. Beaumanoir A, Dravet C. The Lennox-Gastaut syndrome. In: Roger J, Bureau M, Dravet C et al., eds. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. London: John Libbey Eurotext Ltd., 1992:115-32.
32. Hoffmann-Riem M, Diener W, Benninger C, et al. Nonconvulsive status epilepticus: a possible cause of mental retardation in patients with Lennox-Gastaut syndrome. Neuropediatrics 2000;31:169-74.
33. Vigevano F, Fusco L, Pachatz C. Neurophysiology of spasms. Brain Dev 2001;23:467-72.
34. Riikonen R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 1996;37:367-72.
35. Malmgren K, Ben-Menachem E, Frisen L. Vigabatrin visual toxicity: evolution and dose dependence. Epilepsia 2001;42:609-15.
36. Hardus P, Verduin WM, Engelsman M, et al. Visual field loss associated with vigabatrin: quantification and relation to dosage. Epilepsia 2001;42:262-7.
37. Jensen H, Sjo O, Uldall P, et al. Vigabatrin and retinal changes. Doc Ophthalmol 2002;104:171-80.
38. Schmitz B, Schmidt T, Jokiel B, et al. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study. J Neurol 2002;249:469-75.
39. Dulac O, Chugani H, Dalla Bernardina B. Infantile spasms and West syndrome. London: WB Saunders, 1994.